UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Linde
LIN
|
+$940M |
| 2 |
Abbott
ABT
|
+$911M |
| 3 |
Amgen
AMGN
|
+$800M |
| 4 |
Pinduoduo
PDD
|
+$336M |
| 5 |
Advanced Micro Devices
AMD
|
+$289M |
Top Sells
| 1 |
Ametek
AME
|
+$485M |
| 2 |
Microsoft
MSFT
|
+$301M |
| 3 |
Amazon
AMZN
|
+$236M |
| 4 |
VMW
VMware, Inc
VMW
|
+$205M |
| 5 |
TSMC
TSM
|
+$143M |
Sector Composition
| 1 | Technology | 28.1% |
| 2 | Healthcare | 14.47% |
| 3 | Financials | 11.1% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Virtu Financial
VIRT
$3.1B
| $2.26M | ﹤0.01% |
119,683
-3,724
| -3% | -$70.4K |
|
1527
NBT Bancorp
NBTB
$2.27B
| $2.26M | ﹤0.01% |
+67,083
| New | +$2.26M |
|
1528
Freshworks
FRSH
$3.63B
| $2.26M | ﹤0.01% |
146,862
+20,145
| +16% | +$309K |
|
1529
Lindsay Corp
LNN
$1.52B
| $2.25M | ﹤0.01% |
14,896
+1,633
| +12% | +$247K |
|
1530
Plains GP Holdings
PAGP
$3.7B
| $2.25M | ﹤0.01% |
171,498
-1,667
| -1% | -$21.9K |
|
1531
Nelnet
NNI
$4.46B
| $2.24M | ﹤0.01% |
24,397
+1,074
| +5% | +$98.7K |
|
1532
Sylvamo
SLVM
$1.75B
| $2.23M | ﹤0.01% |
48,144
+14,726
| +44% | +$681K |
|
1533
Impinj
PI
$5.2B
| $2.22M | ﹤0.01% |
16,391
-2,397
| -13% | -$325K |
|
1534
Roivant Sciences
ROIV
$9.61B
| $2.21M | ﹤0.01% |
300,009
-26,033
| -8% | -$192K |
|
1535
Verra Mobility
VRRM
$3.92B
| $2.21M | ﹤0.01% |
130,602
-16,614
| -11% | -$281K |
|
1536
Huron Consulting
HURN
$2.44B
| $2.21M | ﹤0.01% |
27,478
-200
| -0.7% | -$16.1K |
|
1537
Reynolds Consumer Products
REYN
$4.84B
| $2.21M | ﹤0.01% |
80,277
+2,022
| +3% | +$55.6K |
|
1538
Methode Electronics
MEI
$287M
| $2.21M | ﹤0.01% |
+50,260
| New | +$2.21M |
|
1539
NMI Holdings
NMIH
$3.08B
| $2.2M | ﹤0.01% |
98,746
+2,558
| +3% | +$57.1K |
|
1540
iShares MSCI Thailand ETF
THD
$235M
| $2.19M | ﹤0.01% |
29,925
| – | – |
|
1541
Knowles
KN
$1.9B
| $2.19M | ﹤0.01% |
129,103
+5,293
| +4% | +$90K |
|
1542
Sabre
SABR
$738M
| $2.19M | ﹤0.01% |
511,294
-19,909
| -4% | -$85.4K |
|
|
NUVA
1543
DELISTED
NuVasive, Inc.
NUVA
| $2.19M | ﹤0.01% |
53,054
+4,892
| +10% | +$202K |
|
1544
Nurix Therapeutics
NRIX
$691M
| $2.19M | ﹤0.01% |
246,711
+1,215
| +0.5% | +$10.8K |
|
1545
PJT Partners
PJT
$4.47B
| $2.17M | ﹤0.01% |
30,030
+6,220
| +26% | +$449K |
|
1546
Northwest Bancshares
NWBI
$1.83B
| $2.17M | ﹤0.01% |
180,041
-5,582
| -3% | -$67.2K |
|
1547
Alcon
ALC
$38.7B
| $2.16M | ﹤0.01% |
30,691
-6,286
| -17% | -$443K |
|
1548
Progyny
PGNY
$1.94B
| $2.16M | ﹤0.01% |
+67,273
| New | +$2.16M |
|
1549
Interparfums
IPAR
$3.43B
| $2.16M | ﹤0.01% |
15,179
-3,821
| -20% | -$543K |
|
1550
Eastern Bankshares
EBC
$3.46B
| $2.16M | ﹤0.01% |
170,787
+28,743
| +20% | +$363K |
|